Evidence map›Paper›PMID 19946436›Full record

ReviewDeutsches Arzteblatt international2009

Good stress, bad stress--the delicate balance in the vasculature.

Kirstin Wingler, Harald H H W Schmidt

Abstract readReview
In one paragraph

Review in Deutsches Arzteblatt international, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Correspondence (letter to the editor): Disputed meta-analyses.Deutsches Arzteblatt international · 2010
    Article
  3. Article
  4. Deleterious effects of reactive metabolites.Oxidative medicine and cellular longevity
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kirstin WinglerMonash University, Department of Pharmacology, Centre for Vascular Health, Melbourne, Australien.
Harald H H W Schmidt

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadicals have important physiological functions, for example, in immune defense and vasoprotection. However, they are also potentially dangerous waste products of cellular metabolism and they can contribute to the development of many different diseases.

methodSelective literature review.

resultsThe scientific understanding of radicals has not yet led to any therapeutic application. For many years, scavenging already formed radicals with antioxidants was considered to be the most promising therapeutic approach, but clinical trials based on this principle have yielded mostly negative results. Thus, entirely new approaches are needed. The goal should be to prevent the formation of harmful radicals, or to treat radical-related damage if it has already occurred. New diagnostic tools have the potential to identify those patients that are most likely to benefit from this form of treatment, as well as to document its success.

conclusionsA new generation of cardiovascular drugs is being developed for the prevention or the mechanism-based treatment of vascular damage caused by oxidative stress. This new therapy should go hand in hand with new diagnostics, in accordance with the principle of individualized medicine.

Indexed as

Models, CardiovascularCardiotonic AgentsFree RadicalsHumansModels, ImmunologicalOxidative StressVascular DiseasesCardiotonic AgentsFree Radicalsantioxidantsnitric oxideoxidative stressradicalsvascular diagnostics

Identifiers

PMID19946436
PMCPMC2780706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.